Trexquant Investment LP

Position in PHAT — Phathom Pharmaceuticals, Inc.

CIK 1633445 STAMFORD, CT

Position in PHAT

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$3,258,618

+$988,708 QoQ

Shares Held

293,305

+114.4% QoQ

Ownership

0.368%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

10 quarters on record

Voting authority Sole 91% Shared 0% None 9%

Healthcare · as of Mar 31, 2026

Trexquant Investment LP holds $496,284,956 across 119 Biotechnology names. PHAT ranks #56 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRNA	Moderna, Inc.	483,971	$24,585,726
2	ALNY	Alnylam Pharmaceuticals, Inc.	61,760	$20,434,531
3	ARWR	Arrowhead Pharmaceuticals, Inc.	277,114	$17,375,047
4	EXEL	Exelixis, Inc.	390,818	$16,762,184
5	HRMY	Harmony Biosciences Holdings, Inc.	594,850	$16,661,748
6	IONS	Ionis Pharmaceuticals Inc	213,645	$16,042,603
7	CNTA	Centessa Pharmaceuticals plc	390,951	$15,528,573
8	ASND	Ascendis Pharma A/S	65,517	$14,985,703

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,258,618	293,305	+114.4%	Shares	Sole	2026-05-15
2025-12-31	$2,269,910	136,824	+75.0%	Shares	Sole	2026-02-17
2025-09-30	$920,213	78,183	-80.4%	Shares	Sole	2025-11-14
2025-03-31	$2,500,168	398,751	+5.3%	Shares	Sole	2025-05-14
2024-12-31	$3,074,532	378,637	+543.7%	Shares	Sole	2025-02-12
2023-09-30	$610,015	58,825	+221.4%	Shares	Sole	2023-11-13
2023-06-30	$262,070	18,301	+22.4%	Shares	Sole	2023-08-11
2022-09-30	$165,701	14,955	-55.1%	Shares	Sole	2022-11-14
2022-06-30	$281,414	33,343	+432.5%	Shares	Sole	2022-08-11
2020-12-31	$208,023	6,262	—	Shares	Sole	2021-02-11
No filing history on record for this holder in this stock.